ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Scope & Guideline

Connecting research and practice in Alzheimer’s and geriatric health.

Introduction

Delve into the academic richness of ALZHEIMER DISEASE & ASSOCIATED DISORDERS with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0893-0341
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1987 to 2024
AbbreviationALZ DIS ASSOC DIS / Alzheimer Dis. Assoc. Dis.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

The journal 'Alzheimer Disease & Associated Disorders' focuses on advancing the understanding of Alzheimer’s disease and related disorders. It aims to publish high-quality research that covers a wide spectrum of topics related to cognitive decline, dementia, and the various factors affecting these conditions.
  1. Cognitive Function and Dementia Assessment:
    Research that explores various methodologies for assessing cognitive function, including neuropsychological tests and imaging techniques, to better understand dementia progression.
  2. Biomarkers and Pathophysiology:
    Studies focusing on identifying biomarkers for Alzheimer's disease and related disorders, as well as understanding the underlying biological mechanisms contributing to neurodegeneration.
  3. Impact of Lifestyle and Environmental Factors:
    Investigations into how lifestyle choices, such as physical activity and diet, as well as environmental factors, influence cognitive health and the risk of dementia.
  4. Caregiver Studies and Psychosocial Aspects:
    Research examining the burden and quality of life for caregivers of Alzheimer’s patients, and the psychosocial impacts of dementia on individuals and families.
  5. Clinical Interventions and Therapeutics:
    Studies investigating various therapeutic approaches, including pharmacological and non-pharmacological interventions, aimed at managing or treating Alzheimer’s disease and related disorders.
  6. Diversity and Health Disparities:
    Research that highlights the differences in Alzheimer’s disease prevalence and outcomes among diverse populations, addressing health disparities in care and access.
Recent publications in 'Alzheimer Disease & Associated Disorders' reveal several emerging themes that reflect the evolving landscape of research in the field. These trends indicate areas of growing interest and relevance.
  1. Holistic and Multidisciplinary Approaches:
    There is an increasing trend towards studies that incorporate multidisciplinary perspectives, including psychological, social, and environmental factors in understanding and managing Alzheimer’s disease.
  2. Prevention and Early Intervention Strategies:
    Research focused on identifying early signs of cognitive decline and implementing preventive strategies is gaining prominence, highlighting the importance of early detection and intervention.
  3. Technology in Dementia Care:
    The use of technology, including digital health tools and telemedicine, in dementia care and research is on the rise, reflecting a shift towards innovative solutions for patient management and research methodologies.
  4. Cultural and Ethnic Studies in Dementia:
    Emerging research is increasingly examining the cultural and ethnic dimensions of dementia care, addressing how cultural factors influence perceptions, diagnosis, and treatment of Alzheimer’s disease.
  5. Neuropsychiatric Symptoms and Behavioral Interventions:
    There is heightened interest in exploring neuropsychiatric symptoms associated with dementia and the development of behavioral interventions to manage these symptoms effectively.

Declining or Waning

While the journal continues to explore a wide range of topics, some areas have shown a decline in focus over recent years. These waning themes may reflect shifts in research priorities or emerging interests in the field.
  1. Genetic Studies in Alzheimer’s Disease:
    Although genetic research remains important, the frequency of publications focusing solely on genetic variants related to Alzheimer’s has decreased, possibly due to a saturation of findings and a shift towards integrative approaches that consider environmental and lifestyle factors.
  2. Animal Models in Alzheimer Research:
    There has been a noticeable decline in studies exclusively using animal models to investigate Alzheimer’s disease, indicating a potential shift towards human-centric research and clinical studies.
  3. Traditional Pharmacological Approaches:
    The focus on traditional pharmacological treatments for Alzheimer’s disease is waning as researchers increasingly explore alternative and complementary therapies, including lifestyle interventions and holistic approaches.

Similar Journals

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Shaping the future of neurology and psychiatry through rigorous scholarship.
Publisher: BMJ PUBLISHING GROUPISSN: 0022-3050Frequency: 12 issues/year

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, published by the esteemed BMJ PUBLISHING GROUP, is a leading journal that covers pivotal research in the fields of neurology, neurosurgery, and psychiatry. With an impressive impact factor and consistently recognized as a Q1 journal in its respective categories—including Clinical Neurology, Psychiatry and Mental Health, and Surgery—this publication ranks in the top percentiles on Scopus, showcasing its influence in the medical community. Since its inception in 1920, the journal has been committed to delivering high-quality, peer-reviewed content to researchers, clinicians, and students alike, maintaining an exceptional reputation attributed to its rigorous selection process and the depth of its contributions. Access to the journal's articles fosters a comprehensive understanding of progressive research and clinical practices, solidifying its significance for professionals aiming to navigate the complexities of neurological and psychiatric disorders. As a vital resource based in the United Kingdom, the journal continues to propel innovation and knowledge sharing in the ever-evolving landscape of neurohealth.

JPAD-Journal of Prevention of Alzheimers Disease

Exploring Breakthroughs in Neurology and Mental Health
Publisher: SPRINGER BASEL AGISSN: 2274-5807Frequency: 4 issues/year

JPAD - Journal of Prevention of Alzheimer’s Disease, published by Springer Basel AG, is a premier academic journal dedicated to advancing research in the critical field of Alzheimer’s disease prevention. Its impactful contributions to the fields of neurology, psychiatry, and mental health have led it to achieve a Q1 ranking in multiple categories, including neurology (clinical) and psychiatry and mental health. Since its inception in 2017, JPAD has become an essential platform for researchers and professionals aiming to stay at the forefront of developments in Alzheimer’s disease research, prevention strategies, and innovative therapies. The journal provides a valuable open access option for disseminating high-quality research to a global audience, enhancing its visibility and impact. With its strategic focus and rigorous peer-review process, JPAD is committed to fostering collaboration and knowledge exchange among scientists, clinicians, and practitioners, ultimately contributing to the global effort to combat Alzheimer's disease.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Pioneering research at the intersection of aging and psychiatry.
Publisher: WILEYISSN: 0885-6230Frequency: 12 issues/year

International Journal of Geriatric Psychiatry, published by Wiley, stands as a premier journal dedicated to advancing the field of mental health in older adults. With an impressive impact factor reflective of its Q1 categorization in both Geriatrics and Gerontology, as well as Psychiatry and Mental Health, this journal addresses the critical intersection of aging and mental health, providing a platform for impactful research from 1986 through 2024. Researchers and professionals will find the journal invaluable, as it offers comprehensive insights into a range of subjects pertinent to geriatric mental health, with its ranking in Scopus highlighting its academic rigor and relevance (Rank #147/567 in Psychiatry and Mental Health; Rank #37/116 in Geriatrics and Gerontology). Though it operates on a traditional subscription model, the journal's significant contributions to the understanding of psychiatric disorders in the elderly make it a key resource for anyone involved in geriatric care and research.

Turkish Journal of Neurology

Empowering research, enhancing understanding in neurology.
Publisher: GALENOS PUBL HOUSEISSN: 1301-062XFrequency: 4 issues/year

Turkish Journal of Neurology, published by GALENOS PUBL HOUSE, is a pivotal open-access journal established in 2004, dedicated to advancing the field of neurology. Renowned for its inclusive approach, this journal serves as a vital platform for researchers and clinicians to share their findings and insights related to neurological disorders and clinical practices, with an emphasis on enhancing the understanding of various neurological conditions affecting populations in Turkey and beyond. Although it holds a Q4 rank in Neurology (Clinical) as per the 2023 category quartiles, the journal's commitment to fostering knowledge exchange remains steadfast, aiming to bridge gaps in clinical research and practice. With an ISSN of 1301-062X and an E-ISSN of 1309-2545, it is indexed in Scopus, ranking 349 out of 400, reflecting its growing presence in the academic sphere. Located in Istanbul, Turkey, the journal invites submissions from both emerging and established researchers to contribute to its diverse content, thereby enhancing its impact on the local and international neurology community.

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY

Connecting research and practice in geriatric mental health.
Publisher: SAGE PUBLICATIONS INCISSN: 0891-9887Frequency: 6 issues/year

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, published by SAGE PUBLICATIONS INC, is a premier academic journal dedicated to advancing the understanding of mental health issues and neurological disorders in the aging population. With an established presence since 1988, this journal stands out in the fields of Geriatrics, Gerontology, Neurology, and Psychiatry, currently positioned in the Q2 category based on 2023 metrics, reflecting its influence and academic rigor. The journal is indexed in major databases and is highly regarded for its contributions, as evidenced by its strong Scopus rankings. It serves as an essential resource for researchers, clinicians, and students, offering insightful articles that explore the complex interplay between aging, mental health, and neurological conditions. Although it does not provide open access, it continues to be a vital source of scholarly knowledge for those dedicated to enhancing the well-being of the elderly population.

JOURNAL OF ALZHEIMERS DISEASE

Exploring the complexities of cognitive decline.
Publisher: IOS PRESSISSN: 1387-2877Frequency: 24 issues/year

Journal of Alzheimer's Disease, published by IOS Press, stands as a pivotal resource in the fight against Alzheimer's and related neurodegenerative disorders. With an ISSN of 1387-2877 and an E-ISSN of 1875-8908, this esteemed journal has evolved since its inception in 1998, providing a vital platform for academic research and clinical practice in the realms of Clinical Psychology, Geriatrics and Gerontology, Neuroscience, and Psychiatry and Mental Health. Ranked in the Q1 category across several disciplines, including Clinical Psychology and Geriatrics, this journal not only highlights significant advancements in understanding Alzheimer's disease but also fosters interdisciplinary dialogue among researchers, healthcare professionals, and policymakers. Boasting robust Scopus rankings—such as 49th in Clinical Psychology and 29th in Geriatrics—this journal is committed to disseminating high-quality research that informs both therapeutic strategies and public health initiatives. The Journal of Alzheimer's Disease is an essential resource for anyone dedicated to exploring the complexities of cognitive decline and enhancing care for affected individuals.

AGING NEUROPSYCHOLOGY AND COGNITION

Connecting scholars to the science of aging minds.
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 1382-5585Frequency: 6 issues/year

AGING NEUROPSYCHOLOGY AND COGNITION, published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, is a leading scholarly journal that spans the interdisciplinary fields of psychology, neuropsychology, and gerontology. With a strong focus on understanding aging processes and cognitive function, this journal serves as a critical platform for researchers, clinicians, and students dedicated to advancing knowledge in the realm of cognitive aging. The journal, established in 1994, presents high-quality research articles, comprehensive reviews, and innovative studies that contribute to the discourse surrounding mental health and aging. Notably, it has been recognized with a 2023 Q2 ranking in Experimental and Cognitive Psychology and Neuropsychology categories, reflecting its significant impact within these domains. The journal includes open access options, making it widely accessible to a global audience. Researchers interested in the latest findings and theoretical developments in aging neuropsychology will find this journal an invaluable resource, further enhanced by its robust Scopus rankings and commitment to academic excellence through 2024 and beyond.

GeroPsych-The Journal of Gerontopsychology and Geriatric Psychiatry

Advancing the Science of Aging and Mental Health
Publisher: HOGREFE AG-HOGREFE AG SUISSEISSN: 1662-9647Frequency: 4 issues/year

GeroPsych - The Journal of Gerontopsychology and Geriatric Psychiatry, published by HOGREFE AG, stands as an essential academic resource in the evolving fields of gerontology and geriatric psychiatry. With a commitment to advancing the understanding of psychological well-being in older adults, the journal provides a platform for high-quality research, discussion, and innovation that caters to researchers, practitioners, and students alike. Although currently not an open-access publication, GeroPsych ensures accessibility through various academic libraries and institutions, fostering a collaborative approach to the complexities of aging and mental health. Recognized within the Q3 category for Geriatrics and Gerontology, and with its impact reflected in Scopus rankings, this journal plays a pivotal role in informing best practices and shaping policies within the interdisciplinary landscape of geriatric care. Spanning research from 2010 to 2024, GeroPsych is positioned as a leading journal for those committed to improving the mental health and psychological resilience of the aging population.

Alzheimers & Dementia

Empowering researchers to tackle Alzheimer’s challenges.
Publisher: WILEYISSN: 1552-5260Frequency: 12 issues/year

Alzheimers & Dementia is a premier journal published by WILEY that focuses on the latest advancements in understanding, diagnosing, and treating Alzheimer's disease and other dementias. With an ISSN of 1552-5260 and an E-ISSN of 1552-5279, this influential journal boasts a commendable impact factor and ranks in the Q1 category across several disciplines, including *Cellular and Molecular Neuroscience*, *Geriatrics and Gerontology*, and *Neurology (Clinical)*. By publishing cutting-edge research, systematic reviews, and innovative clinical trials, Alzheimers & Dementia aims to bridge the gap between basic neuroscience and clinical practice, offering valuable insights into the etiology, epidemiology, and management of dementia-related disorders. The journal is hosted in the United States and operates under a balanced access model, providing essential resources for researchers, healthcare professionals, and students dedicated to tackling the challenges posed by these neurodegenerative diseases. Available online, it plays a pivotal role in shaping current and future research directions in the vibrant field of dementia studies.

Journal of Alzheimers Disease Reports

Elevating the Discourse on Cognitive Disorders
Publisher: IOS PRESSISSN: Frequency: 1 issue/year

Journal of Alzheimer's Disease Reports, published by IOS PRESS, is an essential open-access platform dedicated to advancing research in the fields of clinical psychology, geriatrics, gerontology, neuroscience, and psychiatry. Since its inception in 2017, this journal has rapidly gained recognition, achieving a commendable status reflected in its 2023 category quartiles, notably ranking Q2 in Clinical Psychology and Psychiatry and Mental Health. With a sustained commitment to disseminating high-quality research and facilitating collaboration among scientists, the journal offers insights into the critical aspects of Alzheimer's disease and related cognitive disorders. Given its positions in the Scopus ranks, it serves as a crucial resource for academics and practitioners alike, empowering them to contribute effectively to the ongoing discourse in cognitive health. The journal embraces open access, ensuring that all research findings are freely available to the global community, thereby enhancing visibility and engagement. With a focus on fostering innovation and knowledge transfer, Journal of Alzheimer's Disease Reports is poised to make an enduring impact in the field of dementia research.